News and price dashboard

Bank earnings day, mixed results

The biggest single theme in the feed is the start of Q3 bank reporting. Wells Fargo, covered in full, slipped 1.6% pre-open: net income of $6.0 billion or $1.87 a share was up 13% year over year and a touch above consensus, but revenue of $21.87 billion missed by roughly $440 million, with the shortfall in capital markets and Corporate and Investment Banking, and the Corporate segment posting a loss where income was expected. Net interest income of $12.52 billion also came in light, though management held full-year NII guidance and guided to about $13 billion for Q4. Consumer, Commercial and Wealth all beat. A HUD probe into past mortgage lending programs has been hanging over the name. Alongside that, headline-only items say Goldman Sachs beat by $3.92 with revenue above estimates and profit rising on equities strength, Citi's profit jumped 40% on investment banking, services and wealth, and JPMorgan shares fell as profit missed and fixed-income trading disappointed. Bank of America, Morgan Stanley and BlackRock report Wednesday.

BioNTech trial miss

BioNTech fell nearly 6% pre-open after its mRNA cancer immunotherapy BNT113 failed the first of two dual primary endpoints, progression-free survival, in the AHEAD-MERIT Phase 2/3 trial in unresectable recurrent or metastatic HPV16-positive head and neck squamous cell carcinoma. The trial tested BNT113 plus pembrolizumab against pembrolizumab alone first-line, and the PFS improvement was not statistically significant at this interim look. CMO Özlem Türeci said the data support continued evaluation and show the drug is engaging its intended mechanism. The second dual primary endpoint, overall survival, is still outstanding. The article notes this lands on top of existing uncertainty: co-founders Ugur Sahin and Türeci plan to leave by the end of 2026 to start an independent venture, Sahin's direct shareholding has gone to zero with his stake now held indirectly, and Morgan Stanley had previously trimmed its target. Shares were at $90.15 against a prior close of $95.84, nearer the $79.52 52-week low than the $124 high.

VF upgraded twice on Vans

VF Corp rallied 3.9% pre-open on two upgrades. Piper Sandler went to Overweight from Neutral with a $20 target, up from $16, citing its Fall Teen Survey of roughly 9,000 respondents showing Vans holding a top footwear spot among males and ending a multi-survey decline, plus gains among upper-income male teens. Truist moved to Buy from Hold and nearly doubled its target to $20 from $14, arguing fashion is rotating away from athletic looks and retailers are filling shelf space vacated by Nike lifestyle pullbacks. A JPMorgan upgrade to Neutral the prior session had already helped. Stifel stayed at Hold with a $17 target, flagging Vans wholesale orders as the swing factor. Separately in the feed, a headline-only Piper note says Nike continues to lose teen share as On Running gains, which fits the same survey work.

Domino's beats but comps stall

Domino's fell 3.1% pre-open despite beating on both lines, with diluted EPS of $4.60 against roughly $4.36 expected and revenue of $1.185 billion. The problem was US same-store sales up just 0.3%, down from 5.3% franchise comp growth a year earlier, plus year-to-date operating cash flow off 5.7% to $520.6 million and free cash flow down 7.2% to $459.8 million. It was the first earnings call under new CEO Joe Jordan. Morgan Stanley had cut its target to $357 from $370 the day before, keeping Equalweight and citing category and TAM concerns, quick-service softness and rising rates. The stock sits about 32% below its $442.35 52-week high.

J&J beats on EPS, devices drag

Johnson & Johnson slid 2.5% pre-open. Adjusted EPS of $2.59 beat the $2.53 consensus and revenue of $25.4 billion was slightly ahead and up 5.9%, but GAAP EPS was just $0.09 and GAAP net earnings fell 95.9% to $210 million, reflecting a one-time charge for the proposed talc litigation resolution, the Firefly Bio acquisition and the Sail Biomedicines collaboration. Pharma sales rose 7.7% to $16.76 billion while medtech rose only 2.5% to $8.6 billion, flat outside the US, with the article attributing the weakness to geopolitical issues. Full-year adjusted EPS guidance was raised to $11.05 to $11.15 against $11.08 consensus. The proposed $5.5 billion talc settlement remains conditional on claimant acceptance. The piece notes zero positive and 12 negative EPS revisions in the last 90 days.

Visa gets China clearing approval

Visa rose 1.4% pre-open after the People's Bank of China approved Visa Information Technology (Beijing) to begin formal preparations for a domestic bankcard clearing institution. Visa has up to a year to complete preparations before applying for a full operating licence. CEO Ryan McInerney called it a significant step forward. Mastercard and American Express already hold similar approvals. Baird raised its target to $430 from $420 on Monday with an Outperform rating ahead of fiscal Q4 results on October 27, expecting a modest beat but some growth deceleration into fiscal 2027. The stock set a 52-week high of $391.81 in the prior session and traded to $394.83 pre-market.

Chips, oil and the macro backdrop

The session's wider tone, per the TSX futures piece, was a split tape: Dow futures up, Nasdaq futures down 0.7%, chipmakers under pressure with the industry tracker off 2.7% on Monday and Korean tech hit too, partly on reports of advances by China's ChangXin Memory Technologies narrowing the AI gap. Vital Knowledge noted the debate is why tech has traded so poorly for several sessions. Oil fell after Russia said diesel exports may exceed the volumes in its supply deal with the US, pulling back from Monday's spike that followed Houthi strikes on Saudi infrastructure; gold rebounded. September CPI lands Wednesday, with the Fed expected to hold this month after September's hike. Headline-only items round this out: OPEC raised its 2027 demand growth forecast to 2.55M bpd while cutting 2026 to 180,000 bpd, Saudi production reportedly at about 8.4M b/d in September, the Houthis warning Riyadh of a harsh response, the Kremlin denying the diesel deal is linked to Ukraine talks, and a BofA poll showing tech overweight at its highest since August 2020.

Analyst notes and smaller company items

Mizuho raised Energy Transfer to $26 from $25 with an Outperform rating, expecting commodity earnings to moderate from strong Q2 2026 levels but staying constructive; the note cites the Vaquero acquisition expanding the Delaware footprint as a strategically sensible if pricey bolt-on, projects ramping, and the Waha price recovery reducing optimisation gains. The stock was $20.41, up 30.41% year to date with a 6.66% yield. Needham lifted SentinelOne to $31 from $26, keeping Buy, after a pre-quiet-period conversation convinced it the three emerging products, now over half of total ARR, are not cannibalising endpoint; net revenue retention is back above 110% and revenue grew 21% to $1.1 billion over twelve months. Note the tension in the feed: separate headline-only items say SentinelOne fell 7% after announcing a $1.25 billion convertible notes offering. Dauch Corporation named Nathan Iles CFO effective December 1, joining as SVP Finance on November 2, succeeding Christopher May who becomes EVP and Chief Administrative Officer overseeing IT and HR; Iles was most recently CFO at Standard Motor Products. A long tail of other analyst headlines sits in the list without detail, including Northland cutting Enovix on silicon anode delays, Mizuho cutting Enlight on valuation, Wells Fargo cutting Bristol-Myers on Eliquis concerns, Jefferies initiating Electra at Buy, and Deutsche Bank raising its outlook on semiconductor equipment.

Noise in the feed

A large share of the 200 items is retail chart commentary from TradingView on gold, EURUSD, Bitcoin and index futures, which is directional opinion rather than news, plus routine SEC Form 4 and Form 144 filings with no accompanying detail. Two Trump Truth Social posts were read in full and contain no market content: both are reposts of other users' screenshots, one about Mike Tyson and loyalty, the other a Fox commentary clip about midterm campaigning.

Bumble take-private talks at $1 billion

The biggest single move in the feed is Bumble, up nearly 49.8% in afternoon trading after the Wall Street Journal reported the dating app is in advanced talks to go private at roughly a $1 billion valuation. The buyer is Ithaca Holdings, a newly formed firm set up by two Silicon Valley executives that plans to apply AI and other technology to its portfolio companies, with Bumble among its first major deals. Bumble went into the session with a market cap of about $389 million, so the reported price is close to a tripling of the pre-announcement value. Trading was briefly halted for volatility; the shares hit $3.97 intraday and were last at $3.81, against a 52-week range of $2.44 to $5.96. Founder and CEO Whitney Wolfe Herd, who returned to the role in March 2025, is expected to roll at least part of her stake and stay involved, and an announcement could come as soon as this week if talks hold. Reuters had reported earlier this year that Bumble was exploring a sale as growth in online dating slowed, with rival Match Group facing similar engagement problems. A separate headline-only Investing.com item and a Reuters-sourced piece cover the same story.

Telecom rebound after the SpaceX spectrum shock

The second cluster is the US wireless group unwinding Friday's selloff. T-Mobile rose 2.9% to $152.92 after Raymond James upgraded it to Outperform from Market Perform with a $170 target; analyst Frank Louthan argued the reaction to SpaceX's agreement to buy a nationwide 800 MHz spectrum portfolio was overdone, saying SpaceX is more than three years from a commercially viable nationwide ground network, and pointed to T-Mobile's spectrum holdings and 5G build as advantages the market had discounted. The stock had just set its steepest one-day loss as a public company and had fallen near its 52-week low of $147.90; KeyBanc and StoneX kept positive ratings. Verizon rose 2.4% on the same reversal, having shed nearly 9% on October 9 when SpaceX disclosed the deal with Grain Management. Supporting commentary included Arete Research reiterating Buy with a Street-high $62 target, roughly 49% above Friday's close, and analysis noting Verizon trades near 8x forward earnings against a sector average above 12x, with free cash flow up roughly 24% last quarter and full-year EPS guidance raised to $4.99–$5.04. Verizon also expanded its 6G Innovation Forum to include AWS, Cisco and Intel. AT&T traded higher alongside both. Both articles note the broader market gave no help, with the S&P 500 flat to slightly lower and the Nasdaq down, so this was sector-specific repricing rather than a resolution of the competitive question. Q3 earnings land October 26 for Verizon and October 28 for T-Mobile.

Regulatory filings and routine corporate notices

A large share of the full-text items are bare SEC filing notices with no content beyond the headline: Form 4s for Home Depot, Alphabet Class A, six Sonoco directors dated 1 October, four Northern Oil & Gas directors dated 30 September, and a Form 144 for Dycom. There is nothing in these beyond the fact of the filing. The one filing-adjacent item with actual detail is Barings Corporate Investors, which declared a quarterly dividend of $0.40 per share, payable 13 November to holders of record 2 November, with preliminary Q3 results due 12 November; Barings LLC manages $502 billion as of 30 June 2026. A headline-only companion says Barings Participation Investors declared $0.37.

Analyst actions and 52-week extremes, headline only

Several rating changes appear as headlines with no detail read: Truist upgrading First Solar to Buy from Hold, Wells Fargo upgrading Tyler Technologies to Overweight, KeyBanc initiating IDEXX at Sector Weight, and Maxim initiating Eva Live at Buy. On the price-extreme side, ZIM and Tsakos Energy Navigation hit 52-week highs at $30.96 and $54.06, while Cirrus Logic hit a 52-week low at $106.20 and Morgan Stanley Direct Lending Fund at $13.23. Ciena and Cerebras both have "why is this falling" pieces in the feed that were not read, so the reasons are not available here.

Middle East headlines and energy

A run of newswire headlines points to escalation around the Gulf: three booms reported in Riyadh, a Saudi early-warning alert for a potential hostile threat, UKMTO reporting a container vessel struck by an unknown projectile, Iran denying UK accusations and calling the RAF Fairford incident a false flag, and Canada and Western allies condemning Iran over alleged attacks across Europe. Separately, Russia's Novak is quoted saying Russia has supplied $21.3 billion of energy to the EU this year, may reach 3 to 3.5 million tons of diesel exports by year-end, and that government-level talks with the US on supply are under way. These are all headline-only.

Tech, macro and the rest

Meta is in the feed via headlines on the release of its Muse Wonder AI models positioned against Anthropic and OpenAI, with commentary quoting Mark Zuckerberg on rebuilding the team after Llama 4 disappointed internally. Intel unveiled a GPU D-series for AI inference at the OCP summit. Steris is acquiring surgical safety device maker Xodus Medical. On macro, the Bank of France put Q3 growth at 0.1%, unchanged from the prior estimate, with energy costs and weak manufacturing and construction cited; Fed's Hammack is quoted saying the question now is how fast to make policy more restrictive, and that low-income workers have moved from trading down to juggling which bills to pay. US existing home sales are due Tuesday. The remainder of the 200 items is largely TradingView chart commentary on gold, bitcoin, index levels and individual tickers, agricultural market wraps from Nasdaq, options-flow notes, and political posts, none of which carry reportable substance.

What this feed actually is today

Most of this section is filler. Of the twenty items read in full, three are Investing.com Form 4 insider-filing stubs (Rocket Companies, Doximity, SentinelOne) that contain no filing detail at all beyond the headline, and the other sixteen are Donald Trump Truth Social posts, almost all of them reposts of supporters' tweets about rally crowds, midterm enthusiasm, a Denzel Washington quote card, a Kid Rock clip, and a Tennessee voter saying every day under Trump "is like Christmas." The one piece of concrete content in them: Trump wrote that his next rally stops are Youngstown, Ohio for Senator Jon Husted and Vivek Ramaswamy's governor run, then Alaska for Dan Sullivan and Nick Begich. Nothing market-related. The rest of the 200 items are headline-only, and a large share are individual traders' TradingView chart setups on gold, bitcoin and FX, which carry no news.

Market levels off the Investing.com pages

The one useful thing in the Form 4 pages is the quote board they carry. At capture, FTSE 100 was 10,641.09, up 0.84%, DAX up 0.84%, S&P 500 at 7,811.54 up 0.59% and the Dow up 0.83%. Brent was 106.40, up 1.60%, WTI 93.42, up 1.71%. Gold futures were 4,186.45, down 0.71%, silver down 0.26%, copper up 1.08%. US 10-year at 5.256%, 2-year 4.791%, UK 10-year 5.4374%. UK banks led the movers list: HSBC up 2.02%, Barclays up 1.70%, Lloyds up 1.62%, with Vodafone down 1.10%. Treat the exchange gainer and loser tables on those pages with care, they show absurd prints like Wirecard down 98% and Trane up 430% on handfuls of shares.

Oil, the Gulf and the Russia diesel deal

The busiest real story across the headlines is energy, pulled two ways. Several items reference Houthi missile and drone strikes on Saudi Arabia, with a report of an attack on Riyadh's airport said to have killed at least 12 and injured hundreds, and Iran offering to mediate between Riyadh and the Houthis. Against that, Trump's Russia-Ukraine energy ceasefire and a Russian diesel release are described as softening crude, with one post noting the stated 4.8 million tonnes would cover roughly nine days of US diesel demand. Zelensky is quoted saying Ukraine has influence over whether those ships sail and those refineries run, and Merz said a diesel deal is out of the question for Germany and sanctions should be tightened. Also headline-only: Saudi Arabia raising pipeline crude export capacity to 10m bpd, and Pakistan looking at Libyan crude.

Single-name headlines with something behind them

Bristol Myers Squibb's admilparant met its phase 3 goal in idiopathic pulmonary fibrosis, and there are separate "why is BMY surging today" items alongside it. Salesforce was upgraded to Buy at Bank of America on AI platform trends, carried by both Investing.com and IBD. IonQ is reported buying Elisity for $1.3 billion, IREN reportedly joined Anthropic's cloud providers with shares jumping, and a Hon Hai subsidiary sold its Zhen Ding stake for $3.2 billion. BASF is reported pledging to protect Evonik jobs and German sites in any takeover. Strategy bought 250 BTC for $21.5 million at an average $86,194 and repurchased $192 million of preferred, taking the holding to 848,250 BTC. World Steel cut its 2026 demand forecast on China and war disruption.

The analyst-note pile

A long run of broker headlines, none read in full: Guggenheim raising Everpure to $215 on hyperscaler growth and Elevance to $460, Stephens raising SailPoint, H.C. Wainwright raising Rhythm Pharmaceuticals to $130 on a Japan approval and Kodiak Sciences on trial data, JPMorgan turning bullish on Biogen ahead of 2027 catalysts, StoneX reiterating Buy on Lifeway at $35 and Sell on Roblox, Cantor neutral on Lucid at $8, BTIG downgrading UWM on rate headwinds, and new initiations on Hemab, Quoin and Prenetics. Goldman also named three beneficiaries of high-performance NAND. Insider sales appear at DoorDash, Grindr, OneMedNet, Doximity and Rocket.

What this feed actually is today

Almost nothing in these 200 items is reported news. The twenty items read in full are all Investing.com stubs for SEC Form 4 and Form 144 filings dated 11 October, and every one of them is a headline with no body: no insider name, no share count, no price, no transaction type. The only usable information on those pages is the quote widget and the ticker change shown alongside each filing. The remaining bulk is TradingView user chart posts, mostly on gold, EURUSD and bitcoin, which are individual trade opinions rather than reporting.

Tickers attached to the filing stubs

Taking the figures the filing pages themselves displayed, Humana was the standout at +11.56%. Constellation Energy was +4.56% and FuelCell Energy +4.55% on a Form 144, while Exascale Labs was the worst of the group at -4.90%. Woodward +3.73%, SentinelOne +3.43%, Maravai +3.19%, Natera +2.54% and BETA Technologies +2.34% followed, with Wrap Technologies -3.40%, Sonic Automotive -1.54%, Peoples Bancorp -1.40%, Avidbank -0.96%, UL Solutions -0.93%, Amerant -0.90% and Helmerich and Payne -0.77% on the other side. CoreWeave, Marvell and Jefferies were effectively flat. None of the articles says anything about why any of these moved; the filing and the quote simply sit on the same page.

Insider sales, with amounts

The headline-only items do put numbers on some of the same filings. UL Solutions president and CEO Jennifer Scanlon sold $876k of stock, Beta Technologies CEO Kyle Clark $612,234, SentinelOne CFO Sonalee Parekh $413,291, Marvell's SVP and chief accounting officer $300,949, MediaAlpha CEO Steven Yi $263,320, and Palo Alto Networks director Bawa $103,070. At Onemednet, CEO Aaron Green sold $47,762 and CFO Robert Golden $55,290. Two outliers in the headlines are an InnSuites Hospitality Trust sale by CEO Wirth stated at $2.17 billion and a Mineralrite director selling $106.7m of preferred shares, both figures that look odd against the size of those companies, and neither headline gives any detail behind them. The one purchase in the set is Sonic Automotive director Paul Rusnak buying $1.29m of shares.

Market backdrop carried on those pages

The snapshot repeated across every Investing.com page had the FTSE 100 at 10,552.05, up 1.06%, the DAX up 1.13%, the S&P 500 at 7,811.54 up 0.59% and the Dow up 0.83%, with the Nikkei flat. Metals were the strongest line: gold futures 4,220.30 up 1.52%, silver 61.11 up 2.84%, copper up 2.17%. Brent sat at 104.42, down 0.29%, WTI at 91.66, up 0.19%. UK gilt yields eased across the curve, the 10-year at 5.4457, while US yields rose slightly, the 10-year at 5.244. In single stocks, Vodafone was down 4.86% and BT down 2.38% against gains in HSBC and BHP. This is widget data, not reporting, so there is no explanation attached to any of it.

The handful of real news headlines

A few headline-only items point at actual stories, though I only have the headlines. A prominent Republican senator says Trump's Russian diesel deal may be illegal, and a DeItaone post adds that Senator Thom Tillis is the one raising it, with Bessent defending the deal and Canada objecting. Another DeItaone post says a Witkoff and Kushner trip to Moscow has been put on hold, per Axios. Elsewhere: BridgeBio presented encaleret trial data and dosed a first patient, Stellantis is betting on small affordable EVs for a European comeback, and there are pieces on what the bond sell-off means for monetary policy, US power demand through 2030, and how far the Strategic Petroleum Reserve can be drawn down. A transcript post quotes the JPMorgan CEO warning that higher rates and wider credit spreads can materially change valuations and financing conditions for AI and technology companies.

Noise to be aware of

Two identical posts attributed to RoaringKitty promote trading on the Pump app and claim a large personal payout. Worth knowing they are in the feed and that they are promotional in tone, nothing more.

What this feed actually is

Almost nothing in these 200 items is news. The great majority are automated SEC filing stubs from Investing.com (Form 4 insider transactions, Form 144 notices of proposed sale, a few S-1, 424B5, DEF 14A and 13D/A items) plus a long tail of user-posted TradingView chart ideas on gold, Bitcoin, Nifty and major FX pairs. Twenty items were read in full, and all twenty turned out to be filing stubs with no body text at all: Amkor, Procter & Gamble, EnerSys, SLB, Aramark, Microsoft, Vogenx, Shoulder Innovations, Eton, Afya, Huckleberry.ai, CarGurus and Alkermes on Form 4; Worthington Steel, Artiva, Relay Therapeutics, MongoDB, Porch Group, MeiraGTx and LuxExperience on Form 144. Each page carries only the headline, a timestamp and a ticker tag. There is no transaction size, no insider name, no reason given in any of them.

Market snapshot carried on every page

The one piece of substance in those full-text pages is the site's own market table, which is page furniture rather than reporting, but it is consistent across all twenty. It shows FTSE 100 at 10,552.05, up 1.06%, DAX up 1.13%, S&P 500 up 0.59% at 7,811.54, Dow up 0.83% at 51,654.95, and Nikkei essentially flat at minus 0.02%. Precious metals are the strongest line: silver futures up 2.84% at 61.11 and gold futures up 1.52% at 4,220.30, with copper up 2.17%. Oil is the other way, Brent down 0.29% at 104.42 and WTI roughly flat at 91.66. Among UK single names listed, Vodafone is down 4.86% and BT down 2.38%, against HSBC up 1.10% and BHP up 2.32%. US 2-year and 5-year yields are a touch higher, UK gilt yields a touch lower across the curve.

Insider sales with figures attached

The headline-only insider items do carry numbers, and they are almost entirely sales. Procter & Gamble CFO Andre Schulten sold $568,860 of stock, Ligand Pharmaceuticals CLO Andrew Reardon $1.52 million, Everpure chief accounting officer Mona Chu $399,850, Amkor a director $275,000, Toast CRO Jonathan Vassil $230,168, Eton Pharmaceuticals CBO David Krempa about $229,000, and RingCentral director Amy Shenkan disposed of $99,710. IPG Photonics appears twice, with IP Fibre Devices Ltd selling $1.3 million of stock and director Eugene Scherbakov $259,994. The single buy in the set is a Mueller Water Products director, Healy, purchasing $29,927. These are headlines only, so no explanation accompanies any of them.

The few genuine news headlines

A handful of real stories sit in the feed, all headline-only. Several concern the Riyadh airport attack: organisers say major Saudi conferences will go ahead despite it, and Yemen's Houthis have renewed a warning over Saudi airports following it. Separately, Russian tech group Yandex is reported to have halted its Vladimir data centre after a fresh drone attack. On corporate deals, two Reuters-sourced items say INWIT shareholders are lining up financing for a possible take-private. Deutsche Bank's CEO is reported urging faster German reforms and more flexible labour laws. There is also an analyst roundup, "5 big analyst AI moves," whose headline says Google was reaffirmed as a top pick after the Gemini agent launch, a weekly "Street Calls" piece, and an analysis arguing yen weakness since 2025 has been confined to offshore trading hours.

Chart posts and social noise

The remainder is retail chart commentary, heavily weighted to gold and Bitcoin, and it points in both directions at once: XAU/USD bearish continuation setups sit next to bullish repricing and symmetrical-triangle posts, and Bitcoin ideas range from shorts around 83,100 to targets above 85,000. Treat it as sentiment colour, not information. The X items are Elon Musk promoting Grok's bot, a Saylor one-liner, and a DeltaOne post stating Pope Leo will undergo lung surgery this week after a growth was found on a routine check.

What this feed actually is

Of the 200 items here, the overwhelming majority are routine SEC filing notices (Form 4 insider transactions, Form 144 proposed sales, a few proxy filings) and user-submitted TradingView chart posts. The twenty items read in full were all Investing.com Form 4 stubs, and they contain no article at all beyond the headline, the ticker and a timestamp. UMH Properties, Pacira, Zymeworks, SKYAI, AmeriServ, SharkNinja, Rocket Companies (twice), Iron Mountain, Everpure, Rapport Therapeutics, Duos Technologies, CoreWeave, 908 Devices, GEN Restaurant, Amazon, American Water Works, New Germany Fund, Thor Industries and Global X Funds — that is the full list, and there is nothing behind any of them. Treat this section as low-signal unless you want to dig into individual filings yourself.

Market snapshot carried in those pages

The one genuinely useful thing in the full-text items is the embedded market panel, identical across all of them. European equities were firm: FTSE 100 at 10,552.05, up 1.06%, DAX at 25,087.27, up 1.13%, Euro Stoxx 50 up 0.81%. In the US, the S&P 500 at 7,811.54, up 0.59%, and the Dow at 51,654.95, up 0.83%. The Nikkei was flat at 69,030.92. Metals were the strong corner: gold futures 4,220.30, up 1.52%, silver 61.11, up 2.84%, copper 6.71, up 2.17%. Oil was slightly softer with Brent at 104.42, down 0.29%, and WTI at 91.66, up 0.19%. Gilt yields eased across the curve, UK 10-year at 5.4457, down 0.72%, while US yields rose a touch, 10-year at 5.244 and 2-year at 4.791. On individual UK names in the panel, Vodafone was down 4.86% and BT down 2.38%, against HSBC up 1.10% and BHP up 2.32%. No reason is given for any of these moves — it is a quote table, not reporting.

Insider transactions named in headlines

Several filing headlines do carry dollar figures, all headline-only. On the sell side: Appian CEO Matthew Calkins sold $1.69m of stock, Everpure director Mallun Yen sold $1.75m, Pacific Biosciences' CFO reported a $2.05m sale, Analog Devices director Ray Stata sold $1.17m, Zymeworks EVP Adam Schayowitz sold $357,557 which the headline says was for taxes, Pacira BioSciences SVP Lauren Riker sold $217,920, Rapport Therapeutics CEO Abraham Ceesay sold $143,272, and 908 Devices CFO Joseph Griffith sold $65,150. On the buy side: PIMCO director David Flattum bought roughly $249,000 in each of two PIMCO funds, Saba Capital acquired $210,049 of Ellsworth Growth & Income, Bastion Trading bought $78,262 of SKYAI as a 10% owner, and a Mueller Water Products director bought $29,927. Form 144 notices flagged prospective sales at Marvell, MongoDB, Palantir, Analog Devices, SailPoint, Jazz, Flowers Foods and others.

Geopolitics and energy headlines

A handful of news headlines sit among the filings. A widely-circulated post reports Iran's Revolutionary Guards saying an oil tanker exploded and caught fire after striking a naval mine in the Strait of Hormuz, with the vessel's identity and flag unknown. Separately, Trump is reported demanding Ukraine stop striking Russian oil refineries and saying it is time for Ukraine to get a new president. Also headline-only: Saudi conferences proceeding despite deadly Riyadh airport attacks, Abbas postponing Palestinian elections with a presidential poll set for September 2027, and EU-China trade relations described as hitting crunch time as Brussels pushes for rebalancing. Two OilPrice pieces, on Southeast Asian grid weakness and on the Iran war fuelling a clean-energy boom, are headlines only.

Tech and AI items

Nvidia is reported by the FT to be in talks to invest further in Reflection AI or buy it outright, per a headline-only item. There's a running X exchange between David Sacks and others about whether Anthropic's "alignment" approach to training models is itself a safety risk, plus a White House post claiming tech firms have pledged $2.4bn in computing power to the Genesis Mission. Investing.com also has a piece on consumer AI agents potentially upending online shopping, and Investor's Business Daily names GE Vernova and Snowflake among five AI stocks with accelerating growth. All headline-only.

Chart posts

Roughly half the feed is TradingView user analysis on bitcoin, ether, Solana, gold, oil and various FX pairs, with directional calls in both directions on the same instruments. These are individual traders' posted setups, not reporting, and I'd read them as such.